1. Home
  2. BLND vs XOMA Comparison

BLND vs XOMA Comparison

Compare BLND & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blend Labs Inc.

BLND

Blend Labs Inc.

HOLD

Current Price

$1.43

Market Cap

365.1M

Sector

Technology

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

N/A

Current Price

$36.85

Market Cap

308.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLND
XOMA
Founded
2012
1981
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
365.1M
308.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BLND
XOMA
Price
$1.43
$36.85
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$4.13
$60.60
AVG Volume (30 Days)
4.8M
109.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
58.33
N/A
EPS
N/A
N/A
Revenue
$123,585,000.00
N/A
Revenue This Year
$13.15
$24.59
Revenue Next Year
$14.17
N/A
P/E Ratio
N/A
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$20.00
52 Week High
$4.49
$39.92

Technical Indicators

Market Signals
Indicator
BLND
XOMA
Relative Strength Index (RSI) 36.27 84.37
Support Level N/A $23.96
Resistance Level $1.94 $39.46
Average True Range (ATR) 0.15 1.52
MACD -0.01 0.57
Stochastic Oscillator 1.55 100.00

Price Performance

Historical Comparison
BLND
XOMA

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: